CATH Classification
| Level | CATH Code | Description | 
|---|---|---|
|   | 2 | Mainly Beta | 
|   | 2.60 | Sandwich | 
|   | 2.60.40 | Immunoglobulin-like | 
|   | 2.60.40.150 | C2 domain | 
Domain Context
CATH Clusters
| Superfamily | C2 domain | 
| Functional Family | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 
Enzyme Information
| 2.7.1.153 | Phosphatidylinositol-4,5-bisphosphate 3-kinase. based on mapping to UniProt P48736 ATP + 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate = ADP + 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate. -!- This enzyme also catalyzes the phosphorylation of PtdIns4P to PtdIns(3,4)P(2), and of PtdIns to PtdIns3P. | 
| 2.7.11.1 | Non-specific serine/threonine protein kinase. based on mapping to UniProt P48736 ATP + a protein = ADP + a phosphoprotein. -!- This is a heterogeneous group of serine/threonine protein kinases that do not have an activating compound and are either non-specific or their specificity has not been analyzed to date. -!- Formerly EC 2.7.1.37 and EC 2.7.1.70. | 
UniProtKB Entries (1)
| P48736 | PK3CG_HUMAN Homo sapiens Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 
PDB Structure
| PDB | 3DBS | 
| External Links | |
| Method | X-RAY DIFFRACTION | 
| Organism | |
| Primary Citation | The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer J.Med.Chem. | 
